Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection
Clostridium difficile infection (CDI) may not respond to initial therapy and frequently recurs, but predictors of response and recurrence are inconsistent. The impact of specific alterations in the gut microbiota determining treatment response and recurrence in patients with CDI is unknown.
Alimentary pharmacology therapeutics